SK119896A3 - Inhibitors of clary tryptase, therapeutical and preventive means and their use - Google Patents

Inhibitors of clary tryptase, therapeutical and preventive means and their use Download PDF

Info

Publication number
SK119896A3
SK119896A3 SK1198-96A SK119896A SK119896A3 SK 119896 A3 SK119896 A3 SK 119896A3 SK 119896 A SK119896 A SK 119896A SK 119896 A3 SK119896 A3 SK 119896A3
Authority
SK
Slovakia
Prior art keywords
virus
alp
tryptase
line
viral
Prior art date
Application number
SK1198-96A
Other languages
English (en)
Slovak (sk)
Inventor
Hiroshi Kido
Masato Tashiro
Shozaburo Sekido
Original Assignee
Tokyo Tanabe Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co filed Critical Tokyo Tanabe Co
Publication of SK119896A3 publication Critical patent/SK119896A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1198-96A 1994-03-23 1995-03-20 Inhibitors of clary tryptase, therapeutical and preventive means and their use SK119896A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5223794 1994-03-23
PCT/JP1995/000513 WO1995025539A1 (fr) 1994-03-23 1995-03-20 Nouveau remede contre les maladies virales des voies respiratoires

Publications (1)

Publication Number Publication Date
SK119896A3 true SK119896A3 (en) 1997-04-09

Family

ID=12909121

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1198-96A SK119896A3 (en) 1994-03-23 1995-03-20 Inhibitors of clary tryptase, therapeutical and preventive means and their use

Country Status (16)

Country Link
US (1) US5900401A (fr)
EP (1) EP0804930A1 (fr)
KR (1) KR970701561A (fr)
CN (1) CN1144488A (fr)
AU (1) AU689559B2 (fr)
BG (1) BG100835A (fr)
BR (1) BR9507165A (fr)
CA (1) CA2186111A1 (fr)
CZ (1) CZ265896A3 (fr)
FI (1) FI963753A (fr)
HU (1) HUT75660A (fr)
NZ (1) NZ282488A (fr)
PL (1) PL316444A1 (fr)
RO (1) RO113431B1 (fr)
SK (1) SK119896A3 (fr)
WO (1) WO1995025539A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018072A1 (fr) * 1997-10-07 1999-04-15 Boehringer Ingelheim (Canada) Ltd. Derives d'azetidinone pour le traitement d'infections hcmv
JP2001519328A (ja) * 1997-10-07 2001-10-23 ベーリンガー インゲルハイム （カナダ） リミテッド Ｈｃｍｖ感染症治療のためのアゼチジノン誘導体
DE69810800T2 (de) * 1997-10-07 2003-09-18 Boehringer Ingelheim Ca Ltd Azetidinonderivate zur behandlung von hcmv entzündungen
US8679462B2 (en) * 2002-04-11 2014-03-25 Saeed Rezakhany Methods of preventing respiratory infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000077A1 (fr) * 1984-06-14 1986-01-03 Cortech, Inc. Inhibiteurs d'elastase de leucocytes humains, prepares a partir de bacteries pyogenes et procede de purification de ces substances
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
ATE92935T1 (de) * 1984-12-06 1993-08-15 Synergen Biolog Inc Serinproteaseinhibitoren und isolierungsverfahren dazu.
HU204563B (en) * 1984-12-06 1992-01-28 Synergen Biolog Inc Process for producing recombinant serine-protease inhibitors and dns sequencyes for them
JPS62501291A (ja) * 1984-12-06 1987-05-21 サイナ−ゲン　バイオロジカルズ，インコ−ポレ−テツド 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物
DE3600571A1 (de) * 1986-01-10 1987-08-06 Gruenenthal Gmbh Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel
US5290762A (en) * 1986-12-24 1994-03-01 John Lezdey Treatment of inflammation
CA1340877C (fr) * 1987-12-28 2000-01-18 Takashi Sugiyama Polypeptide inhibant l'elastage et procede de production par la technologie de l'adn recombinant
DE3841873A1 (de) * 1988-12-13 1990-06-21 Gruenenthal Gmbh Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen
JP3961029B2 (ja) * 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
US5334141A (en) * 1992-06-26 1994-08-02 Medrad, Inc. Extravasation detection system and apparatus
SK281127B6 (sk) * 1992-09-09 2000-12-11 Amgen Inc. Použitie inhibítora serínovej leukocytovej proteázy
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase

Also Published As

Publication number Publication date
HU9602598D0 (en) 1996-11-28
CN1144488A (zh) 1997-03-05
NZ282488A (en) 1999-09-29
CA2186111A1 (fr) 1995-09-28
FI963753A0 (fi) 1996-09-20
PL316444A1 (en) 1997-01-20
FI963753A (fi) 1996-09-20
BR9507165A (pt) 1997-09-09
CZ265896A3 (en) 1997-06-11
EP0804930A1 (fr) 1997-11-05
BG100835A (en) 1997-06-30
US5900401A (en) 1999-05-04
HUT75660A (en) 1997-05-28
KR970701561A (ko) 1997-04-12
AU1961195A (en) 1995-10-09
EP0804930A4 (fr) 1997-11-05
WO1995025539A1 (fr) 1995-09-28
AU689559B2 (en) 1998-04-02
RO113431B1 (ro) 1998-07-30

Similar Documents

Publication Publication Date Title
Beppu et al. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses
Klenk et al. Host cell proteases controlling virus pathogenicity
Tashiro et al. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity
Ovcharenko et al. Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice
JP6869979B2 (ja) 新規なトリプシンアイソフォームおよびそれらの使用
AU2016204793B2 (en) Modified DNase and uses thereof
JP2010515729A5 (fr)
US20100196285A1 (en) Use of Deuterium Oxide to Treat Virus-Based Diseases of the Respiratory Tract
JPH08505405A (ja) ウィルスのエアロゾールの調製方法
SK119896A3 (en) Inhibitors of clary tryptase, therapeutical and preventive means and their use
Kido et al. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
WO1982003011A1 (fr) Agent de traitement des maladies des organes respiratoires
Akaike et al. Potentiation of infectivity and pathogenesis of influenza A virus by a house dust mite protease
NZ532019A (en) Anti-influenza drugs
MXPA96004207A (en) Novedous remedy for tractor pyrrato viral disease
EP1596851B1 (fr) Utilisation de 2-mercapto-ethane sulfonate de sodium en tant qu'agent antiviral
WO2013066214A2 (fr) Composition pharmaceutique d'aérosol d'inhibiteur de protéases et sa fabrication
US20130064792A1 (en) Therapy for influenza like illness
Zhirnov et al. Replication of influenza B virus in chicken embryos is suppressed by exogenous aprotinin
WO2024096742A1 (fr) Polypeptide de liaison au sars-cov-2
EP4380549A1 (fr) Formulation de peptidase pour le traitement d'infections microbiennes dans les voies respiratoires supérieures
WO2023081198A1 (fr) Méthodes et compositions comprenant des cristaux d'acide protocatéchuique pour le traitement d'états provoqués par un virus enveloppé
AGENT Piazza et al.(43) Pub. Date: Aug. 24, 2006
EA040577B1 (ru) Комбинированный аэрозольный состав на основе ингибиторов протеаз и его получение